{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:27:34Z","timestamp":1793662054924,"version":"4.5.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T00:00:00Z","timestamp":1310169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12348-011-0027-9","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T18:03:52Z","timestamp":1310148232000},"page":"177-180","source":"Crossref","is-referenced-by-count":41,"title":["Rituximab in refractory Vogt\u2013Koyanagi\u2013Harada disease"],"prefix":"10.1186","volume":"1","author":[{"given":"Rosa","family":"Dolz-Marco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gallego-Pinazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"D\u00edaz-Llopis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,9]]},"reference":[{"key":"27_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/IAE.0b013e3181c5970d","volume":"30","author":"DV Vasconcelos-Santos","year":"2010","unstructured":"Vasconcelos-Santos DV, Sohn EH, Sadda S, Rao NA (2010) Retinal pigment epithelial changes in chronic Vogt\u2013Koyanagi\u2013Harada disease. Retina 30:33\u201341","journal-title":"Retina"},{"key":"27_CR2","first-page":"157","volume":"22","author":"M D\u00edaz-Llopis","year":"2004","unstructured":"D\u00edaz-Llopis M, Navea A, Peris C, Amselem L, Pin\u00f3s J, Salom D, Hern\u00e1ndez ML (2004) S\u00edndrome de Vogt-Koyanagi-Harada, actualizaci\u00f3n. Studium Ophthalologicum 22:157\u2013166","journal-title":"Studium Ophthalologicum"},{"key":"27_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0002-9394(00)00851-5","volume":"131","author":"H Inomata","year":"2001","unstructured":"Inomata H, Rao NA (2001) Depigmented atrophic lesions in sunset glow fundi of Vogt\u2013Koyanagi\u2013Harada disease. Am J Ophthalmol 131:607\u2013614","journal-title":"Am J Ophthalmol"},{"key":"27_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/09273940500536766","volume":"14","author":"I Paredes","year":"2006","unstructured":"Paredes I, Ahmed M, Foster CS (2006) Immunomodulatory therapy for Vogt\u2013Koyanagi\u2013Harada patients as first-line therapy. Ocul Immunol Inflamm 14:87\u201390","journal-title":"Ocul Immunol Inflamm"},{"key":"27_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000103239","volume":"39","author":"C Tappeiner","year":"2007","unstructured":"Tappeiner C, Heinz C, Specker C, Heilighenhaus A (2007) Rituximab as a treatment option for refractory endogenous anterior uveitis. Ophthalmic Res 39:184\u2013186","journal-title":"Ophthalmic Res"},{"key":"27_CR6","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/bjo.2006.113316","volume":"91","author":"J Freidlin","year":"2007","unstructured":"Freidlin J, Wong IG, Acharya N (2007) Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis. Br J Ophthalmol 91:1414","journal-title":"Br J Ophthalmol"},{"key":"27_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ophtha.2009.05.029","volume":"117","author":"D Khanna","year":"2010","unstructured":"Khanna D, Chong KK, Afifiyan NF, Hwang CJ, Lee DK, Garneau HC, Goldberg RA, Darwin CH, Smith TJ, Douglas RS (2010) Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology 117:133\u2013139","journal-title":"Ophthalmology"},{"key":"27_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ophtha.2010.07.031","volume":"118","author":"E Miserocchi","year":"2011","unstructured":"Miserocchi E, Pontikaki I, Modorati G, Bandello F, Meroni PL, Gerloni V (2011) Rituximab for uveitis. Ophthalmology 118:223\u2013224","journal-title":"Ophthalmology"},{"key":"27_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2006.02.049","volume":"142","author":"RW Read","year":"2006","unstructured":"Read RW, Yu F, Accorinti M, Bodaghi B, Chee SP, Fardeau C, Goto H, Holland GN, Kawashima H, Kojima E, Lehoang P, Lemaitre C, Okada AA, Pivetti-Pezzi P, Secchi A, See RF, Tabbara KF, Usui M, Rao NA (2006) Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt\u2013Koyanagi\u2013Harada disease. Am J Ophthalmol 142:119\u2013124","journal-title":"Am J Ophthalmol"},{"key":"27_CR10","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1136\/bjo.2008.153981","volume":"93","author":"L Niccoli","year":"2009","unstructured":"Niccoli L, Nannini C, Cassar\u00e0 E, Gini G, Lenzetti I, Cantini F (2009) Efficacy of infliximab therapy in two patients with refractory Vogt\u2013Koyanagi\u2013Harada disease. Br J Ophthalmol 93:1553\u20131554","journal-title":"Br J Ophthalmol"},{"key":"27_CR11","first-page":"131","volume":"82","author":"M D\u00edaz Llopis","year":"2007","unstructured":"D\u00edaz Llopis M, Amselem L, Romero FJ, Garc\u00eda-Delpech S, Hern\u00e1ndez ML (2007) Adalimumab therapy for Vogt\u2013Koyanagi\u2013Harada syndrome. Arch Soc Esp Oftalmol 82:131\u2013132","journal-title":"Arch Soc Esp Oftalmol"},{"key":"27_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3109\/09273940903267936","volume":"17","author":"Y Khalifa","year":"2009","unstructured":"Khalifa Y, Loh AR, Acharya NR (2009) Fluocinolone acetonide intravitreal implants in Vogt\u2013Koyanagi\u2013Harada disease. Ocul Immunol Inflamm 17:431\u2013433","journal-title":"Ocul Immunol Inflamm"},{"key":"27_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ajo.2003.08.035","volume":"137","author":"RE Andrade","year":"2004","unstructured":"Andrade RE, Muccioli C, Farah ME, Nussenblatt RB, Belfort R Jr (2004) Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt\u2013Koyanagi\u2013Harada syndrome. Am J Ophthalmol 137:572\u2013574","journal-title":"Am J Ophthalmol"},{"key":"27_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00417-010-1477-8","volume":"249","author":"HS Park","year":"2011","unstructured":"Park HS, Nam KY, Kim JY (2011) Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt\u2013Koyanagi\u2013Harada disease. Graefes Arch Clin Exp Ophthalmol 249:133\u2013136","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"27_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/archneurol.2010.99","volume":"67","author":"L Piccio","year":"2010","unstructured":"Piccio L, Naismith RT, Trinkaus K, Klein RS, Parks BJ, Lyons JA, Cross AH (2010) Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Arch Neurol 67:707\u2013714","journal-title":"Arch Neurol"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12348-011-0027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12348-011-0027-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12348-011-0027-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12348-011-0027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T15:46:26Z","timestamp":1572795986000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12348-011-0027-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,9]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1007\/s12348-011-0027-9","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,9]]}}}